Fund Overview
13F Filed: 2026-02-13As of 2025 Q4, Clal Insurance Enterprises Holdings Ltd manages $16M in reported 13F assets , holds 212 positions with +54.27% top-10 concentration , and delivered a 1-year return of +46.36% on its disclosed equity portfolio. Filing 13F reports since 2014.
About
Investment Strategy
Activity Summary — 2025 Q4
Top Buys
| Stock | % Impact |
|---|---|
| TEVA TEVA PHARMACEUT.. | +3.47% |
| SPY SPDR S&P 500 ET.. | +3.12% |
| VOO VANGUARD INDEX .. | +3.04% |
| ESLT ELBIT SYS LTD O.. | +1.99% |
| RSP INVESCO EXCHANG.. | +1.98% |
| VHT VANGUARD WORLD .. | +1.62% |
Top Sells
| Stock | % Impact |
|---|---|
| QQQM INVESCO EXCH TR.. | -1.66% |
| IWM ISHARES TR RUSS.. | -1.38% |
| EEM ISHARES TR MSCI.. | -0.87% |
| KBWB INVESCO EXCH TR.. | -0.72% |
| ORCL ORACLE CORP COM.. | -0.62% |
| MU MICRON TECHNOLO.. | -0.52% |
Activity Summary
Sector Allocation Trends
Holdings Analysis
Positions Dynamics
Portfolio Analytics — Latest
Clal Insurance Enterprises Holdings Ltd risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.
Tracking institutional benchmark deviation
Best Strategy vs. Benchmarks
Strategy Backtester: Clal Insurance Enterprises Holdings Ltd
Replicate top holdings performance • Compare vs benchmarks • Optimize N
Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.
Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.
⏱ Run Backtest
Liquid Glass Edition
👆 Click the button to launch tickers!
Backtesting Clal Insurance Enterprises Holdings Ltd's top 10 holdings against SPY identified 35 underperformance periods. Worst drawdown: 2021-02 – 2021-04 (-25.9% vs SPY, 3 quarters).
The ticker-level breakdown shows how each of Clal Insurance Enterprises Holdings Ltd's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: ESLT (2021 Q2 – 2025 Q3, +13.5 pts), TEVA (2021 Q1 – 2025 Q3, +11.3 pts), VOO (2022 Q1 – 2025 Q3, +9.3 pts), QQQM (2023 Q1 – 2025 Q3, +8.2 pts), NVMI (2025 Q1 – 2025 Q3, +6.5 pts) .
Frequently Asked Questions
What does Clal Insurance Enterprises Holdings Ltd invest in?
What is Clal Insurance Enterprises Holdings Ltd's AUM?
How concentrated is Clal Insurance Enterprises Holdings Ltd's portfolio?
How to track Clal Insurance Enterprises Holdings Ltd 13F filings?
Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.